Albuminuria

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

KidneYou - Innovative Digital Therapy

Clinical Findings and Albuminuria as Predictors of Acute Kidney Injury in Patients With Acute Heart Failure

Screening for Albuminuria at the First Line for Early Identification of CKD

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension

Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes

Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands